Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
Clinical trial NCT00101803 · COMPLETED
Trial details
- NCT number
- NCT00101803
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2006-01-01
- Enrollment
- 527
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.